Montserrat Estruch Alrich
5PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 17, 2025
The glycosaminoglycan oncofetal chondroitin sulfate is a novel target for antibody-drug conjugate therapy for AML.Joana Mujollari, Montserrat Estruch, Priya Khadgawat
|Mar 05, 2022
Inhibition of Oxidized Nucleotide Sanitation By TH1579 and Conventional Chemotherapy Cooperatively Enhance Oxidative DNA Damage and Survival in AML.Anders Centio, Montserrat Estruch, Kristian Reckzeh
|Oct 01, 2021
MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia.Kumar Sanjiv, José Manuel Calderón-Montaño, Therese M Pham
|Dec 10, 2020
Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapy.Montserrat Estruch, Kristian Reckzeh, Camilla Vittori
|Jul 11, 2018
Human adult HSCs can be discriminated from lineage-committed HPCs by the expression of endomucin.Kristian Reckzeh, Hüsün Kizilkaya, Alexandra Søgaard Helbo
Pageof 1
Frequent Collaborators
5 joint publications
Kim Theilgaard-Mönch
3 joint publications
Kristian Reckzeh
2 joint publications
Sophia Engelhard
2 joint publications
Bo T Porse
2 joint publications
Kristen Grønbæk
2 joint publications
Ulrika Warpman Berglund
1 joint publications
Mette Agerbæk
1 joint publications
José Manuel Calderón-Montaño
1 joint publications
Brinton Seashore-Ludlow
1 joint publications
Camilla Göktürk
